Team

Principal Investigator

Elena Ioana Braicu, M.D., Ph.D.

Professor of Translational Gynecological Oncology; TOC Director; Head of the Gynecological Oncology Clinical Trials Unit

Prof. Dr. Elena Ioana Braicu is a physician-scientist with over 15 years of expertise in gynecologic oncology, specializing in translational research, biomarker discovery, and innovative clinical trial design. As Medical Director of the Clinical Trial Unit at Charité and NOGGO, she has coordinated over 30 Phase I–IV clinical trials across multiple institutions, pioneering adaptive trial designs and novel combination therapies to overcome resistance mechanisms in ovarian cancer.

Prof. Dr. Braicu has authored over 200 peer reviewed publications and played a pivotal role in advancing ovarian cancer treatment strategies, including optimizing surgical timing and enhancing therapeutic outcomes. She co-founded and leads the Translational Research Committee and Biobank of the European Network for Gynecological Oncological Trial Groups (ENGOT). Additionally, she heads the Tumor Bank Ovarian Cancer, strengthening global research collaborations and data sharing.

Her contributions have earned prestigious honors, including the Feodor Lynen Fellowship (Humboldt Foundation) and the Stanford Endowed Scholarship. Actively engaged in professional societies such as ESGO, ASCO, and AGO, Dr. Braicu regularly contributes to clinical guidelines, advisory boards, and international oncology conferences.

Prof. Dr. Braicu is deeply committed to mentoring the next generation of clinical researchers, having guided over 14 Ph.D. and M.D. candidates. Her leadership in bridging academic insights with clinical application has positioned her as a trusted collaborator among key opninion leaders and pharmaceutical partners. Passionate about accelerating the translation of cutting- edge science into next-generation therapies, Dr. Braicu is dedicated to reshaping the treatment landscape for women with gynecologic malignancies. Quality Management